Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212K Buy
+2,800
New +$211K ﹤0.01% 4957
2025
Q1
Sell
-20,800
Closed -$1.5M 3273
2024
Q4
$1.5M Buy
20,800
+6,400
+44% +$500K ﹤0.01% 2079
2024
Q3
$1.17M Buy
+14,400
New +$1.15M ﹤0.01% 1971
2024
Q2
Sell
-24,300
Closed -$1.89M 2686
2024
Q1
$1.89M Buy
24,300
+9,500
+64% +$707K ﹤0.01% 1392
2023
Q4
$1.06M Buy
+14,800
New +$1.03M ﹤0.01% 1413

Other funds holding HOLX

IMC Chicago's HOLX Position: Q4 2023 in Review

IMC Chicago sold out of Hologic (HOLX) in Q4 2023, closing a stake of 10,581 shares — an estimated $737K sold.

IMC Chicago first reported a position in HOLX in Q3 2023 and held it in 1 quarter. The position peaked at $734K in Q3 2023. 732 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • IMC Chicago reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • IMC Chicago sold 10,581 Hologic shares in Q4 2023, an estimated $737K.
  • IMC Chicago first reported a position in Hologic in Q3 2023 and held it in 1 quarter.
  • IMC Chicago's Hologic position peaked at $734K in Q3 2023.
  • 732 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on IMC Chicago's 13F filing for Q4 2023, filed 9 Feb 2024.